Navigation Links
Bush Again Vetoes Embryonic Stem Cell Research Bill

President George W. Bush on Wednesday vetoed for a second time a bill seeking to encourage potentially groundbreaking embryonic stem cell research, saying it violates the sanctity of human life. Risking new criticism from the scientific community, Bush rejected moves by US lawmakers to overturn his earlier prohibition against using federal funds for any research involving human embryo destruction.

It is only the third time in six years as president that he has wielded his veto; the first time was last year when he blocked a similar bill on federal support for embryonic stem cell research. The president, a devout Christian, said that using human embryos for scientific research -- which often involves their destruction -- conflicts with his religious beliefs and he urged scientists to consider other alternatives. "If this legislation became law, it would compel American taxpayers for the first time in our history to support the deliberate destruction of human embryos," Bush said.

"I made it clear to Congress and to the American people that I will not allow our nation to cross this moral line." Embryonic stem cells are primitive cells from early stage embryos capable of developing into almost every tissue of the body. Scientists believe they could be crucial to finding a cure for a number of serious diseases, including Parkinson's and Alzheimer's, diabetes and cancer. But Bush, criticized for holding back promising research after the 2006 veto, offered new support to encouraging alternative stem cell research.

"We're already seeing remarkable advances in science and therapeutic uses of stem cells drawn from adults and children and the blood from umbilical cords with no harm to the donor," he said. "For example, several new studies released earlier this month showed the potential of reprogramming adult cells, such as skin cells, to make them function like embryonic stem cells.

"A few months earlier, scientists dis covered that cells extracted from amniotic fluid and placentas could also provide stem cells that seem to do what embryonic cells can." Bush added: "Our conscious calls us to pursue the possibilities of science in a manner that respects human dignity and upholds our moral values." Immediately after the veto, Democratic Senator Hillary Clinton hit out at Bush for holding back scientific research.

"This is just one example of how the president puts ideology before science, politics before the needs of our families," said Clinton, who is seeking the Democratic nomination for the presidential election next year. Bush also announced directives toward encouraging alternatives to stem cell research reliant on human embryos, directing the Department of Health and Human Services and the National Institutes of Health to ensure than human stem cell lines are "prodcued in ways that do not create, destroy or harm human embryos." Those that follow such orders "will be eligible for federal funding," Bush said.

Researchers have announced their recent success in reprogramming mouse skin cells to mimic the properties of embryonic stem cells, in an advance they hope can be replicated in humans. "By expanding support for nondestructive research methods, this executive order will make it more likely that these exciting advances continue to unfold," the White House said after Bush signed the executive order.

As before, Bush's rejection of the legislation does not prevent private money to be used for embryonic stem cell work. Private foundations and some states have offered funds for research with embryonic stem cells in the wake of Bush's previous veto.


'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Diabetics Need to Guard Against Nail Fungus
3. Spinal Cord Patients Walk Again
4. New Weapon Against Germs
5. Estrogen Found To Protect the Colon Against Cancer
6. Diet Found To Offer Protection Against Leukemia
7. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
8. WHO Issues Caution Against Bird Flu Epidemic
9. New Supplement Found To Be Effective Against Sunburn
10. Intense Fight Against Polio In India Gets Results
11. Prime Minister Manmohan Against Incentive-Based Population Control
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over ... of Medicare Part D a decade ago, according to The Senior Citizens League ... on how they are coping with rapidly rising costs. “The implications are chilling, ...
(Date:2/10/2016)... ... February 09, 2016 , ... According to a recent ... dramatic increase in the number of patients under the age of 30. According to ... seeing in their offices, and may indicate an overall shift in the rapidly growing ...
(Date:2/9/2016)... Nevada (PRWEB) , ... February 09, 2016 , ... ... providing treatment to Medicaid beneficiaries who are diagnosed with autism spectrum disorder (ASD). ... Nevada. Autism treatment using applied behavior analysis (ABA) is key to providing ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... compensation fee schedule rates and Medicare rates for a variety of medical services ... report, Evaluation of the 2015 Fee Schedule Rates in Illinois, are ...
(Date:2/9/2016)... NY (PRWEB) , ... February 09, 2016 , ... Establishment ... appointment of Dr. David Hung to the company´s Board of Directors. , ... world class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  Increasingly, health care professionals are enhancing patient ... wireless technology. With the Vios Monitoring System from Vios ... remotely detect problems before they become serious by continuously ... the United States . ... --> The Vios Monitoring System connects ...
(Date:2/9/2016)... Feb. 9, 2016  Johnson & Johnson (NYSE: ... Global Healthcare Conference on Tuesday, Feb. 23, at the ... Caruso , Vice President, Finance & Chief Financial Officer ... represent the Company in a session scheduled at 10:00 ... --> www.investor.jnj.com . --> This webcast ...
(Date:2/9/2016)... , Feb. 9, 2016 Athenex, Inc. announced ... as Vice President of Corporate Strategy and Business Development based ... MBA has joined as Senior Director and Deputy Head of Clinical Research ... . Simon Pedder stated, "Athenex has a ... a while. Coupled together with their unique business model and ...
Breaking Medicine Technology: